Form 8-K SANUWAVE Health, Inc. For: Jun 11
Tweet
Share
E-mail1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
| Date of Report (Date of earliest event reported) | |||||
| (Exact name of registrant as specified in its charter) | ||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||
| Registrant’s telephone number, including area code | ||||||||
| N/A | ||
| (Former name or former address, if changed since last report) | ||
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
| Common stock, par value $0.001 per share | SNWV | The Nasdaq Stock Market LLC | ||||||
Indicate by check mark whether the registration is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
1
2
Item 5.07 Submission of Matters to a Vote of Security Holders.
On June 11, 2026, Sanuwave Health, Inc. (the “Company”) held its 2026 annual meeting of stockholders. The following matters (the “Proposals”) were voted upon by the stockholders with the final voting results as shown:
Proposal 1. To elect five directors, Morgan Frank, Gregory Bazar, Jeffrey Blizard, Ian Miller and James Tyler, to serve until the 2027 annual meeting of stockholders.
| Name | Votes For | Withheld | Broker Non-Votes | |||||||||||||||||
| Morgan Frank | 4,988,463 | 69,863 | 1,061,530 | |||||||||||||||||
| Gregory Bazar | 4,706,567 | 351,759 | 1,061,530 | |||||||||||||||||
| Jeffrey Blizard | 4,634,031 | 424,295 | 1,061,530 | |||||||||||||||||
| Ian Miller | 4,244,965 | 813,361 | 1,061,530 | |||||||||||||||||
| James Tyler | 4,292,161 | 766,165 | 1,061,530 | |||||||||||||||||
Proposal 2. To ratify the appointment of Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
| Votes For | Votes Against | Abstain | Broker Non-Votes | |||||||||||||||||
| 6,057,957 | 45,261 | 16,638 | – | |||||||||||||||||
Proposal 3. To approve, in an advisory, non-binding vote, the compensation paid to the Company’s named executive officers.
| Votes For | Votes Against | Abstain | Broker Non-Votes | |||||||||||||||||
| 4,666,444 | 385,238 | 6,644 | 1,061,530 | |||||||||||||||||
2
3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| SANUWAVE HEALTH, INC. | ||||||||
| Dated: June 15, 2026 | By: | /s/ Morgan C. Frank | ||||||
| Name: | Morgan C. Frank | |||||||
| Title: | Chief Executive Officer | |||||||
3
ATTACHMENTS / EXHIBITS
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Press Release: Sanofi’s Wayrilz approved in Japan to treat immune thrombocytopenia
- Port Orange HVAC Firm Purchases 220 Charles St Building
- Growth Hero™ Platform Targets Local Demand Gaps for Franchise Operators
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
